Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells That Contribute to the Fibrous Cap

English version České info

Coronary artery disease (CAD) is responsible for the majority of deaths in the Western world, and is due in part to environmental and metabolic factors. However, half of the risk for developing heart disease is genetically predetermined. Genome-wide association studies in human populations have identified over 100 sites in the genome that appear to be associated with CAD, however, the mechanisms by which variation in these regions are responsible for predisposition to CAD remain largely unknown. We have begun to study a gene that contributes to CAD risk, the TCF21 gene. Through genomic studies we show that this gene is involved in processes related to alterations in vascular gene expression, and in particular those related to the smooth muscle cell biology. With cell culture models, we show that TCF21 regulates the differentiation state of this cell type, which is believed critical for vascular disease. Using mouse genetic models of atherosclerotic vascular disease we provide evidence that this gene is expressed in precursor cells that migrate into the disease lesions and contribute to the formation of the fibrous cap that is believed to stabilize these lesions and prevent heart attacks.

Vyšlo v časopise: Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells That Contribute to the Fibrous Cap. PLoS Genet 11(5): e32767. doi:10.1371/journal.pgen.1005155
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1005155

Souhrn

Zdroje

1. Daviglus ML, Talavera GA, Aviles-Santa ML, Allison M, Cai J, et al. (2012) Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States. JAMA: the journal of the American Medical Association 308: 1775–1784. doi: 10.1001/jama.2012.14517 23117778

2. Gupta R, Gupta KD (2009) Coronary heart disease in low socioeconomic status subjects in India: "an evolving epidemic". Indian heart journal 61: 358–367. 20635739

3. Ikem I, Sumpio BE (2011) Cardiovascular disease: the new epidemic in sub-Saharan Africa. Vascular 19: 301–307. doi: 10.1258/vasc.2011.ra0049 21940758

4. Almahmeed W, Arnaout MS, Chettaoui R, Ibrahim M, Kurdi MI, et al. (2012) Coronary artery disease in Africa and the Middle East. Therapeutics and clinical risk management 8: 65–72. doi: 10.2147/TCRM.S26414 22368447

5. Gomez D, Owens GK (2012) Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc Res 95: 156–164. doi: 10.1093/cvr/cvs115 22406749

6. Deloukas P, Kanoni S, Willenborg C, Farrall M, Assimes TL, et al. (2012) Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet 45: 25–33. doi: 10.1038/ng.2480 23202125

7. Lu X, Wang L, Chen S, He L, Yang X, et al. (2012) Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease. Nat Genet 44: 890–894. doi: 10.1038/ng.2337 22751097

8. Schunkert H, Konig IR, Kathiresan S, Reilly MP, Assimes TL, et al. (2011) Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 43: 333–338. doi: 10.1038/ng.784 21378990

9. Cui S, Ross A, Stallings N, Parker KL, Capel B, et al. (2004) Disrupted gonadogenesis and male-to-female sex reversal in Pod1 knockout mice. Development 131: 4095–4105. 15289436

10. Cui S, Schwartz L, Quaggin SE (2003) Pod1 is required in stromal cells for glomerulogenesis. Dev Dyn 226: 512–522. 12619136

11. Hidai H, Bardales R, Goodwin R, Quertermous T, Quertermous EE (1998) Cloning of capsulin, a basic helix-loop-helix factor expressed in progenitor cells of the pericardium and the coronary arteries. Mech Dev 73: 33–43. 9545526

12. Lu J, Chang P, Richardson JA, Gan L, Weiler H, et al. (2000) The basic helix-loop-helix transcription factor capsulin controls spleen organogenesis. Proc Natl Acad Sci U S A 97: 9525–9530. 10944221

13. Lu J, Richardson JA, Olson EN (1998) Capsulin: a novel bHLH transcription factor expressed in epicardial progenitors and mesenchyme of visceral organs. Mech Dev 73: 23–32. 9545521

14. Lu JR, Bassel-Duby R, Hawkins A, Chang P, Valdez R, et al. (2002) Control of facial muscle development by MyoR and capsulin. Science 298: 2378–2381. 12493912

15. Quaggin SE, Schwartz L, Cui S, Igarashi P, Deimling J, et al. (1999) The basic-helix-loop-helix protein pod1 is critically important for kidney and lung organogenesis. Development 126: 5771–5783. 10572052

16. Robb L, Mifsud L, Hartley L, Biben C, Copeland NG, et al. (1998) epicardin: A novel basic helix-loop-helix transcription factor gene expressed in epicardium, branchial arch myoblasts, and mesenchyme of developing lung, gut, kidney, and gonads. Dev Dyn 213: 105–113. 9733105

17. Acharya A, Baek ST, Huang G, Eskiocak B, Goetsch S, et al. (2012) The bHLH transcription factor Tcf21 is required for lineage-specific EMT of cardiac fibroblast progenitors. Development 139: 2139–2149. doi: 10.1242/dev.079970 22573622

18. Braitsch CM, Combs MD, Quaggin SE, Yutzey KE (2012) Pod1/Tcf21 is regulated by retinoic acid signaling and inhibits differentiation of epicardium-derived cells into smooth muscle in the developing heart. Dev Biol 368: 345–357. doi: 10.1016/j.ydbio.2012.06.002 22687751

19. Feng J, Mantesso A, Sharpe PT (2010) Perivascular cells as mesenchymal stem cells. Expert opinion on biological therapy 10: 1441–1451. doi: 10.1517/14712598.2010.517191 20836622

20. Sheikh AY, Chun HJ, Glassford AJ, Kundu RK, Kutschka I, et al. (2008) In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure. Am J Physiol Heart Circ Physiol 294: H88–98. 17906101

21. Anders S, Huber W (2010) Differential expression analysis for sequence count data. Genome Biol 11: R106. doi: 10.1186/gb-2010-11-10-r106 20979621

22. Robinson MD, McCarthy DJ, Smyth GK (2010) edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26: 139–140. doi: 10.1093/bioinformatics/btp616 19910308

23. Soneson C, Delorenzi M (2013) A comparison of methods for differential expression analysis of RNA-seq data. BMC Bioinformatics 14: 91. doi: 10.1186/1471-2105-14-91 23497356

24. Mack CP, Owens GK (1999) Regulation of smooth muscle alpha-actin expression in vivo is dependent on CArG elements within the 5' and first intron promoter regions. Circ Res 84: 852–861. 10205154

25. Arab K, Smith LT, Gast A, Weichenhan D, Huang JP, et al. (2011) Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma. Carcinogenesis 32: 1467–1473. doi: 10.1093/carcin/bgr138 21771727

26. Barnes RM, Firulli AB (2009) A twist of insight—the role of Twist-family bHLH factors in development. Int J Dev Biol 53: 909–924. doi: 10.1387/ijdb.082747rb 19378251

27. Li W, Li Q, Jiao Y, Qin L, Ali R, et al. (2014) Tgfbr2 disruption in postnatal smooth muscle impairs aortic wall homeostasis. J Clin Invest 124: 755–767. doi: 10.1172/JCI69942 24401272

28. Inamoto S, Kwartler CS, Lafont AL, Liang YY, Fadulu VT, et al. (2010) TGFBR2 mutations alter smooth muscle cell phenotype and predispose to thoracic aortic aneurysms and dissections. Cardiovasc Res 88: 520–529. doi: 10.1093/cvr/cvq230 20628007

29. Mellgren AM, Smith CL, Olsen GS, Eskiocak B, Zhou B, et al. (2008) Platelet-derived growth factor receptor beta signaling is required for efficient epicardial cell migration and development of two distinct coronary vascular smooth muscle cell populations. Circ Res 103: 1393–1401. doi: 10.1161/CIRCRESAHA.108.176768 18948621

30. Zhang Y, Riesterer C, Ayrall AM, Sablitzky F, Littlewood TD, et al. (1996) Inducible site-directed recombination in mouse embryonic stem cells. Nucleic Acids Res 24: 543–548. 8604292

31. Acharya A, Baek ST, Banfi S, Eskiocak B, Tallquist MD (2011) Efficient inducible Cre-mediated recombination in Tcf21 cell lineages in the heart and kidney. Genesis 49: 870–877. doi: 10.1002/dvg.20750 21432986

32. Alexander MR, Owens GK (2012) Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu Rev Physiol 74: 13–40. doi: 10.1146/annurev-physiol-012110-142315 22017177

33. Owens GK, Kumar MS, Wamhoff BR (2004) Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84: 767–801. 15269336

34. Funato N, Ohyama K, Kuroda T, Nakamura M (2003) Basic helix-loop-helix transcription factor epicardin/capsulin/Pod-1 suppresses differentiation by negative regulation of transcription. J Biol Chem 278: 7486–7493. 12493738

35. Orlandi A, Bennett M (2010) Progenitor cell-derived smooth muscle cells in vascular disease. Biochemical pharmacology 79: 1706–1713. doi: 10.1016/j.bcp.2010.01.027 20117099

36. Frid MG, Aldashev AA, Nemenoff RA, Higashito R, Westcott JY, et al. (1999) Subendothelial cells from normal bovine arteries exhibit autonomous growth and constitutively activated intracellular signaling. Arterioscler Thromb Vasc Biol 19: 2884–2893. 10591665

37. Holifield B, Helgason T, Jemelka S, Taylor A, Navran S, et al. (1996) Differentiated vascular myocytes: are they involved in neointimal formation? J Clin Invest 97: 814–825. 8609239

38. Sainz J, Al Haj Zen A, Caligiuri G, Demerens C, Urbain D, et al. (2006) Isolation of "side population" progenitor cells from healthy arteries of adult mice. Arterioscler Thromb Vasc Biol 26: 281–286. 16306431

39. Majesky MW, Dong XR, Hoglund V, Mahoney WM Jr., Daum G (2011) The adventitia: a dynamic interface containing resident progenitor cells. Arterioscler Thromb Vasc Biol 31: 1530–1539. doi: 10.1161/ATVBAHA.110.221549 21677296

40. Zengin E, Chalajour F, Gehling UM, Ito WD, Treede H, et al. (2006) Vascular wall resident progenitor cells: a source for postnatal vasculogenesis. Development 133: 1543–1551. 16524930

41. Virmani R, Burke AP, Farb A, Kolodgie FD (2006) Pathology of the vulnerable plaque. J Am Coll Cardiol 47: C13–18. 16631505

42. Kozaki K, Kaminski WE, Tang J, Hollenbach S, Lindahl P, et al. (2002) Blockade of platelet-derived growth factor or its receptors transiently delays but does not prevent fibrous cap formation in ApoE null mice. Am J Pathol 161: 1395–1407. 12368212

43. Sano H, Sudo T, Yokode M, Murayama T, Kataoka H, et al. (2001) Functional blockade of platelet-derived growth factor receptor-beta but not of receptor-alpha prevents vascular smooth muscle cell accumulation in fibrous cap lesions in apolipoprotein E-deficient mice. Circulation 103: 2955–2960. 11413086

44. Li G, Jin R, Norris RA, Zhang L, Yu S, et al. (2010) Periostin mediates vascular smooth muscle cell migration through the integrins alphavbeta3 and alphavbeta5 and focal adhesion kinase (FAK) pathway. Atherosclerosis 208: 358–365. doi: 10.1016/j.atherosclerosis.2009.07.046 19695571

45. Litvin J, Chen X, Keleman S, Zhu S, Autieri M (2007) Expression and function of periostin-like factor in vascular smooth muscle cells. Am J Physiol Cell Physiol 292: C1672–1680. 17092992

46. Lindner V, Wang Q, Conley BA, Friesel RE, Vary CP (2005) Vascular injury induces expression of periostin: implications for vascular cell differentiation and migration. Arterioscler Thromb Vasc Biol 25: 77–83. 15514205

47. Hixson JE, Shimmin LC, Montasser ME, Kim DK, Zhong Y, et al. (2011) Common variants in the periostin gene influence development of atherosclerosis in young persons. Arterioscler Thromb Vasc Biol 31: 1661–1667. doi: 10.1161/ATVBAHA.111.224352 21474826

48. Bentzon JF, Falk E (2010) Circulating smooth muscle progenitor cells in atherosclerosis and plaque rupture: current perspective and methods of analysis. Vascular pharmacology 52: 11–20. doi: 10.1016/j.vph.2009.11.005 19951745

49. Yu H, Stoneman V, Clarke M, Figg N, Xin HB, et al. (2011) Bone marrow-derived smooth muscle-like cells are infrequent in advanced primary atherosclerotic plaques but promote atherosclerosis. Arterioscler Thromb Vasc Biol 31: 1291–1299. doi: 10.1161/ATVBAHA.110.218578 21372299

50. Miller CL, Anderson DR, Kundu RK, Raiesdana A, Nurnberg ST, et al. (2013) Disease-Related Growth Factor and Embryonic Signaling Pathways Modulate an Enhancer of TCF21 Expression at the 6q23.2 Coronary Heart Disease Locus. PLoS Genet 9: e1003652. doi: 10.1371/journal.pgen.1003652 23874238

51. Miller CL, Haas U, Diaz R, Leeper NJ, Kundu RK, et al. (2014) Coronary Heart Disease-Associated Variation in TCF21 Disrupts a miR-224 Binding Site and miRNA-Mediated Regulation. PLoS Genet 10: e1004263. doi: 10.1371/journal.pgen.1004263 24676100

52. Chen YC, Bui AV, Diesch J, Manasseh R, Hausding C, et al. (2013) A novel mouse model of atherosclerotic plaque instability for drug testing and mechanistic/therapeutic discoveries using gene and microRNA expression profiling. Circ Res 113: 252–265. doi: 10.1161/CIRCRESAHA.113.301562 23748430

53. Aono J, Suzuki J, Iwai M, Horiuchi M, Nagai T, et al. (2012) Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice. Arterioscler Thromb Vasc Biol 32: 1453–1459. doi: 10.1161/ATVBAHA.112.249516 22460554

54. Hidai C, Zupancic T, Penta K, Mikhail A, Kawana M, et al. (1998) Cloning and characterization of developmental endothelial locus-1: an embryonic endothelial cell protein that binds the alphavbeta3 integrin receptor. Genes Dev 12: 21–33. 9420328

55. Perisic L, Hedin E, Razuvaev A, Lengquist M, Osterholm C, et al. (2013) Profiling of atherosclerotic lesions by gene and tissue microarrays reveals PCSK6 as a novel protease in unstable carotid atherosclerosis. Arterioscler Thromb Vasc Biol 33: 2432–2443. doi: 10.1161/ATVBAHA.113.301743 23908247